Rami El Abiad | University of Iowa Clinical Research and Trials

Attention Site Visitor

You are currently visiting the UI Health Care Clinical Trials website on a version of the web browser: Internet Explorer. Internet Explorer is no longer being supported by Microsoft, and there are features and functionality on this website that does not operate properly when using Internet Explorer. If you have an alternative browser, such as: Microsoft Edge, Google Chrome, Mozilla Firefox, or Apple Safari, we suggest you switch to that browser for the optimal viewing experience.

Thank you

Studies

Uniquity One NSI-8226-201 EE (ALAMERE)

Internal Medicine Immunology Gastroenterology Esophagitis Digestive Disease Adult Subjects

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solrikitug in adult participants with eosinophilic esophagitis.

Celldex CDX0159-08 EoE

Internal Medicine Immunology Gastroenterology Esophagitis Digestive Disease Adult Subjects

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adult Eosinophilic Esophagitis patients.

AstraZeneca D5244C00001 Crossing EoE

Internal Medicine Immunology Gastroenterology Esophagitis Digestive Disease Adult Subjects

A randomized, double-blind, placebo-controlled multicenter, phase 3 study to evaluate the efficacy and safety of tezepelumab administered subcutaneously (SC) using an accessorized pre-filled syringe (APFS) versus placebo in adult and adolescent patients with eosinophilic esophagitis (EoE).